ALNY - $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | Benzinga
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 10 years by 4.95% on an annualized basis producing an average annual return of 15.84%. Currently, Alnylam Pharmaceuticals has a market capitalization of $31.40 billion.
Buying $100 In ALNY: If ...